Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in Moderately Active Crohn's Disease
NCT00731172Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Sep 2008
- Primary completion
- Jul 2010
- Countries
- 1
01
Overview
A Phase 2 trial of glatiramer acetate in Crohn's disease, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
glatiramer acetate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00731172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731172.